November 20, 2015
Horizon disagrees with Court. Won’t buy Depomed
Judge Peter Kirwan of the Superior Court of California for the County of Santa Clara has granted Depomed motion for…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
November 19, 2015
FDA nods to Narcan nasal spray-used to stop opioid overdose
The U.S. Food and Drug Administration approved Narcan nasal spray on Wednesday. Narcan is the first FDA-approved nasal spray version of…
November 19, 2015
Lilly and Merck move on with oncology clinical trial of and Keytruda
Eli Lilly and Merck are moving on with an existing oncology clinical trial collaboration to evaluate the safety and efficacy of the combination of Lilly’s Almita (pemetrexed for injection) and Merck’s Keytruda (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).
November 19, 2015
Sanofi CEO: Health must be part of the Climate debate
Sanofi will participate to Solutions COP21, the United Nations conference on climate change, as an official partner, a public exhibition in Paris.
November 19, 2015
Biofrontera concludes clinical phase III of BCC study. Approval of Ameluz expected in 2016
Biofrontera has concluded the clinical phase 3 of BCC study as the last patient in the ongoing phase has had its final clinical visit.
November 19, 2015
American Medical Association calls for ban on direct to consumer advertising of RX drugs and medical devices
The United States and New Zealand are the only two countries in the world that allow direct-to-consumer advertising of prescription drugs.
November 19, 2015
Strides Arcolab Limited becomes Strides Shasun Limited
India-headquartered pharmaceutical company, Strides Arcolab Limited has change its name to Strides Shasun Limited.
November 19, 2015
Indian IOLCP boosts Ibuprofen plant capacity
IOLCP has completed its De-bottlenecking/ Re-engineering project for its Ibuprofen Manufacturing facilities at Barnala with project cost of Rs 24 Crores, and has started the enhanced production from Thursday.
November 19, 2015
(Edited) Dr Reddy’s refutes allegations
Dr. Reddy’s Laboratories has issued a press release reacting to certain statements that appeared in the certain media on Thursday.
November 18, 2015
Health Canada to review Janssen’s NDS for daratumumab for Multiple Myeloma
Health Canada has accepted for review Janssen’s new drug submission (NDS) for daratumumab for treatment of Multiple Myeloma.